Progress of research in treatment of hyperlipidemia by monomer or compound recipe of Chinese herbal medicine.
Hyperlipidemia (HLP) is the No.1 risk factor for patients with atherosclerosis (AS) and is directly related to the occurrence of coronary artery disease (CAD) and cerebrovascular disease. Therefore, prevention and treatment of AS is of great importance and of practical significance in controlling the incidence and mortality of CAD. With its peculiar syndrome-dependent therapy, traditional Chinese medicine (TCM) has accumulated abundant practical experiences in this field and good clinical effects have been achieved. Chinese herbal medicine, with its particularly unique advantages and high potentials yet to be tapped, displays its huge strength in HLP prevention and treatment. The progress of studies concerning prevention and treatment of HLP by Chinese herbal medicines, in the form of monomers or compound recipes, is reviewed in this paper.
Dou
Xiao-bing
XB
Zhejiang University of Chinese Medicine, Hangzhou, 310053, China. snow@taijispear.net
Wo
Xing-de
XD
Fan
Chun-lei
CL
D002784:Cholesterol / Q000378:metabolism; D004365:Drugs, Chinese Herbal / Q000627:therapeutic use*; D006801:Humans; D006949:Hyperlipidemias / Q000188:drug therapy*; D050356:Lipid Metabolism; D015227:Lipid Peroxidation; D011973:Receptors, LDL / Q000032:analysis
D004365:Drugs, Chinese Herbal; D011973:Receptors, LDL; D002784:Cholesterol